"Finnish Cerenion has raised 500 000 euros in seed funding for its groundbreaking brain monitoring technology that holds great potential for improving intensive care…To date, the development of the technology and business has been funded by more than 1.1 million euros."
Good News from Finland
"Oulu’s ICT-focused enterprises are on track to raise a record amount of development capital in 2018, based on venture capital funding activity in January-February. Cerenion Oy is a case in point."
ComputerWeekly.com
"Cerenion is a unique combination of deep research and a great complementary team that is creating a leader of a completely new category in healthcare. Their product will greatly help doctors in their work and save lives."
Riku Seppälä, Partner, Icebreaker.vc
"The team is a great combination of different kinds of skills and expertise. Furthermore, they’re very execution focused and they have taken the case far already before the investment, both in terms of product as well as clinical validation. Superb team together with strong IP, clear market entry path and scalable business model are the ingredients that Cerenion is made of."
Juho Risku, Managing Partner, Butterfly Ventures
Board
Terho Hoskonen
Chairman of the Board of Directors
Janek Frantzén
Adjunct Professor, Department of Clinical Medicine, University of Turku
Member of the Board of Directors
Anssi Ylimaula
Member of the Board of Directors
Janne Laakso
Member of the Board of Directors
Jon Unnérus
Member of the Board of Directors
Advisors
Atsuhiro Nakagawa
Professor, Tohoku University Hospital, Japan
External advisor
Jan Ekström
External advisor
Mika Kallio
Medical advisor
Visit us
Contact us
Cerenion Oy has received support from the European Regional Development Fund of the European Union.
OULU
Cerenion Oy Elektroniikkatie 3 90590 Oulu FINLAND
HELSINKI
Cerenion Oy Kyllikinportti 2 00240 Helsinki FINLAND